One of my favorite bloggers (Peter Lloyd-Thomas) has been blogging about PPAR-Gamma Agonists and autism recently here http://epiphanyasd.blogspot.com/2015/05/tangeretin-vs-ibuprofen-as-ppar.html.
Among Peter’s observations:
1) Actos improves behavior in autism, and Actos is a PPAR-gamma agonist. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781426/
2) PPAR-gamma agonists have antiepileptic properties in mice. http://grantome.com/grant/NIH/R01-NS085389-01A1#panel-abstract-body
3) Peter’s son who has autism is doing better on PPAR-gamma agonists and no longer needs ibuprofen.
Some additional observations:
4) Cntnap2 gene defect ameliorated with biochanin A in Zebrafish. https://imfar.confex.com/imfar/2015/webprogram/Paper20670.html Biochanin A is a PPAR-gamma agonist.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212005/
5) Luteolin formulations have shown efficacy in autism in some open label trials: http://europepmc.org/abstract/med/22697063, http://www.clinicaltherapeutics.com/article/S0149-2918(13)00178-1/abstract Luteolin is a partial PPAR-gamma agonist. http://www.ncbi.nlm.nih.gov/pubmed/22391103.
6) IGF-1 seems to show some efficacy in Phellan McDermid syndrome: http://www.molecularautism.com/content/5/1/54. An herb that upregulates IGF-1 also upregulates PPAR-gamma. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117754/ Is IGF-1 also a PPAR-gamma agonist?
I am going to IMFAR 2015 in Salt Lake City and will be giving a poster presentation on “Effectiveness of Over-the-counter therapies for autism”. The presentation is on Friday, May 15 between 11:30 AM and 1:30 PM.
Here is my main poster:
Here are my two tables:
Here is a top 10 list of autism research ideas: